World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01509495
Date of registration: 07/12/2011
Prospective Registration: No
Primary sponsor: Medtronic BRC
Public title: Impedance Measurements in Heart Failure Patients SIM-HF
Scientific title: Impedance Measurements in Heart Failure Patients
Date of first enrolment: December 2011
Target sample size: 20
Recruitment status: Terminated
URL:  http://clinicaltrials.gov/show/NCT01509495
Study type:  Interventional
Study design:  Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic  
Phase:  Phase 1
Countries of recruitment
Czech Republic Germany Slovakia
Contacts
Name:     Eva Goncalvesova, Prof.
Address: 
Telephone:
Email:
Affiliation:  NUSCH, Cardiac Surgery, Pod Krasnou horkou 1, 83348 Bratislava, Slovakia
Name:     Sebastian KG Maier, Prof.
Address: 
Telephone:
Email:
Affiliation:  Klinikum St. Elisabeth Straubing, Med. Klinik II, St.-Elisabeth-Str. 23, 94315 Straubing, Germany
Name:     Petr Neuzil, Prof.
Address: 
Telephone:
Email:
Affiliation:  Nemocnice Na Homolce, Cardiology, Roentgenova 2/37, 150 30 Praha 5, Czechia
Key inclusion & exclusion criteria

Inclusion Criteria:

- patients admitted to hospital for symptoms of congestive heart failure

- patients older than 18 years

- patients willing and able to give informed consent

Exclusion Criteria:

- patients who will require adrenergic or positive inotropic medications

- patients enrolled in a concurrent study that may confound the results of this study

- patients unable or unwilling to participate in study procedures

- patients who are pregnant

- patients who are mentally handicapped or legal incompetent

- patients who are dependent on investigator or sponsor



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Heart Failure
Intervention(s)
Device: Akern BIA101 and Custom Device
Primary Outcome(s)
Impedance Measurement of Patients in Heart Failure, impedance change first to last measurement [Time Frame: every 4 hours up to 48 hours]
Secondary Outcome(s)
Correlation between hemodynamic (central venous or arterial pressure) and impedance measurements (optional) [Time Frame: every 4 hours up to 48 hours]
Accuracy of Respiratory rate determined by impedance measurements [Time Frame: every 4 hours up to 48 hours]
Secondary ID(s)
RAE00564
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history